USD10
BNTC azioni
Informazioni su Benitec BiopharmaBenitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
USD10
BNTC azioni
Informazioni su Benitec BiopharmaBenitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
Statistiche
FINESTRA DI NEGOZIAZIONE
Chiusa
APRE ALLE
20 mar at 13:30 GMT+0
Capitalizzazione di mercato
376,12 Mln USD
PREZZO DI APERTURA
11,49 USD
MINIMO (1 anno)
9,85 USD
MASSIMO (1 anno)
17,15 USD
MINIMO (24H)
10,93 USD
MASSIMO (24 ore)
11,64 USD
VOLUME (24 ore)
716,31K USD
497,21%
Cronologia dei prezzi
Time | Price | Change |
|---|---|---|
Oggi | 11,49 USD | |
1 giorno | 11,25 USD | |
1 settimana | 12,04 USD | |
1 mese | 10,85 USD | |
1 anno | 16,11 USD |